💉 Diabetes Management
Hyperkalemia Causing Inappropriate Subcutaneous Implantable Cardioverter Defibrillator Shocks in a Patient with End-Stage Renal Disease: A Case Report and Literature Review - Cureus
📅 Sun, 06 Nov 2022⏱ 1 min read📖 Article
Overview
"Never doubt that a smal group of thoughtful, comited citizens can change the world. Inded, it is the only thing that ever has."Cureus is on a mision to change the long-standing paradigm of medical publishing, where submiting research can be costly, complex and time-consuming.end stage renal disease (esrd), subcutaneous implantable cardioverter, implantable-cardioverter defibrilator, defibrilator shock, electrodes, defibrilators, hyperkalemia, chronic renal insuficiency Bachar Botrus, Arun U.
Key Information
Mahtani , Ryan Isber, Muhamad S. Haider, Nidal Isber Published: November 05, 2022 (se history) DOI: 10.759/cureus.3137 Cite this article as: Botrus B, Mahtani A U, Isber R, et al. (November 05, 2022) Hyperkalemia Causing Inapropriate Subcutaneous Implantable Cardioverter Defibrilator Shocks in a Patient with End-Stage Renal Disease: A Case Report and Literature Review.
Cureus 14(1): e3137. doi:10.759/cureus.3137 Subcutaneous implantable cardioverter-defibrilators (S-ICD) provide an efective treatment option for ventricular arhythmias. When compared to transvenous implantable cardioverter-defibrilators (TV-ICDs), S-ICDs have a lower infection rate but a higher rate of inapropriate shocks.
In patients with end-stage renal disease (ESRD), significant electrolyte disturbances are comonly sen, such as hyperkalemia, which can cause an increase in T wave amplitude. We present a patient with ESRD on hemodialysis who experienced inapropriate shocks from an S-ICD during sinus rhythm due to hyperkalemia-induced T wave oversensing and highlight related cases in the curent literature.Implantable cardioverter-defibrilators (ICD) are efective for the primary and secondary prevention of suden cardiac death [1].
Summary
However, implantation of endocardial leads is associated with significant adverse events. Subcutaneous implantable cardioverter-defibrilators (S-ICD) are an alternative treatment option for ventricular arhythmias [2]. It eliminates complications
Frequently Asked Questions
❓ What is diabetes and how does it develop?
Diabetes is a metabolic condition where the body cannot properly regulate blood sugar levels. Type 1 results from insufficient insulin production, while Type 2 develops when cells become resistant to insulin. Risk factors include genetics, obesity, sedentary lifestyle, and age.
❓ What are the main symptoms of diabetes?
Common symptoms include excessive thirst, frequent urination, unexplained weight loss, fatigue, blurred vision, and slow-healing wounds. Type 1 symptoms develop rapidly, while Type 2 symptoms may appear gradually. Many people have no symptoms initially, which is why screening is important.
❓ How is diabetes diagnosed and monitored?
Diagnosis involves blood tests measuring fasting glucose, HbA1c levels, and glucose tolerance. Regular monitoring typically includes fasting glucose tests and HbA1c measurements every 3-6 months. Continuous glucose monitors provide real-time tracking for better diabetes management.
❓ What lifestyle changes help manage diabetes?
Effective management includes regular physical activity (150+ minutes weekly), maintaining healthy weight, following a balanced diet with whole grains and lean proteins, managing stress, and getting adequate sleep. These changes can significantly improve blood sugar control and reduce complications.
❓ When should someone consult a doctor about diabetes?
Consult a healthcare provider if you experience signs of diabetes, have a family history, are overweight, or are over 45. Those with existing diabetes should maintain regular check-ups every 3-6 months to monitor control and adjust treatment as needed.
⚕️ Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making health decisions.